<!doctype html><html lang=en><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><title>GSK sues Pfizer over patents for RSV vaccine | SwiftBlog</title><meta name=generator content="Hugo 0.98.0"><meta name=description content="GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.
The case, filed in federal court in the state of Delaware, pits the producers of the only two approved vaccines for respiratory syncytial virus (RSV) against each other.
The United States on May 3 approved GSK's Arexvy as the first vaccine for RSV; that was followed on May 31 with US approval of Pfizer's Abrysvo."><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cayman/css/normalize.css><link href="https://fonts.googleapis.com/css?family=Open+Sans:400,700" rel=stylesheet type=text/css><link rel=stylesheet href=https://assets.cdnweb.info/hugo/cayman/css/cayman.css><link rel=apple-touch-icon sizes=180x180 href=./apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=./favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=./favicon-16x16.png><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/katex.min.css integrity=sha384-yFRtMMDnQtDRO8rLpMIKrtPCD5jdktao2TV19YiZYWMDkUR5GQZR/NOVTdquEx1j crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/katex.min.js integrity=sha384-9Nhn55MVVN0/4OFx7EE5kpFBPsEMZxKTCnA+4fqDmg12eCTqGi6+BB2LjY8brQxJ crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.10.2/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body)></script></head><body><section class=page-header><h1 class=project-name>SwiftBlog</h1><h2 class=project-tagline></h2><nav><a href=./index.html class=btn>Blog</a>
<a href=./sitemap.xml class=btn>Sitemap</a>
<a href=./index.xml class=btn>RSS</a></nav></section><section class=main-content><h1>GSK sues Pfizer over patents for RSV vaccine</h1><div><strong>Publish date: </strong>2024-09-17</div><img style=margin:auto;display:block;text-align:center;max-width:100%;height:auto src=https://cdn.statically.io/img/netstorage-legit.akamaized.net/images/498916209007dfc0.jpg><p class=align-left>GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.</p><p class=align-left>The case, filed in federal court in the state of Delaware, pits the producers of the only two approved vaccines for respiratory syncytial virus (RSV) against each other.</p><p class=align-left>The United States on May 3 approved GSK's Arexvy as the first vaccine for RSV; that was followed on May 31 with US approval of Pfizer's Abrysvo. Both vaccines have since been approved by the European Union.</p><p class=align-left>"Upon information and belief, Pfizer knowingly uses GSK's claimed inventions in Abrysvo without permission," said the GSK complaint.</p><p class=align-left>The complaint describes Arexvy as "the result of more than 15 years of research and development by GSK scientists," adding that Pfizer's program on an RSV vaccine began "no earlier than 2013."</p><a class=c-article-read-also__image-wrapper href=#><img sizes=256px style=margin:auto;display:block;text-align:center src=https://cdn.statically.io/img/netstorage-legit.akamaized.net/images/19b77a0406d5422c.jpg></a><a class=c-article-read-also__headline href=# readability=27><p class=c-article-read-also__caption>Read also</p><p class=c-article-read-also__headline-wrapper><span class=c-article-read-also__headline-hover-inner>Senegal suspends TikTok after unrest</span></p></a><p class=align-left>The lawsuit lists four GSK patents granted by US officials between 2013 and 2023 that Pfizer is alleged to have infringed.</p><p class=align-left>The suit seeks compensation for lost profits and royalties and a permanent ban on Pfizer selling the product in the United States.</p><p class=align-left>RSV is a widespread, highly contagious pathogen most known for causing bronchiolitis -- an irritation and inflammation of the small airways -- in young children, especially in winter.</p><p class=align-left>It also infects adults and <a href=#>can</a> become dangerous in the elderly, who may develop pneumonia.</p><p class=align-left>Pfizer did not immediately respond to a request for comment.</p><p>Source: AFP</p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmivp6x7rbHGoqtnppdkr7a%2FyKecrKtdmrCwus6msGhpZWmEc36UZp6so12owqa%2FjKmdorKVp3qxrdOepa2rXafAt3nVmpqcoZ6afA%3D%3D</p><footer class=site-footer><span class=site-footer-credits>Made with <a href=https://gohugo.io/>Hugo</a>. Â© 2022. All rights reserved.</span></footer></section><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/banner.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>